ClinConnect ClinConnect Logo
Search / Trial NCT06348810

Dual-Task Training for People With Mild Cognitive Impairment and Mild Dementia

Launched by TAIPEI MEDICAL UNIVERSITY · Mar 30, 2024

Trial Information

Current as of May 22, 2025

Not yet recruiting

Keywords

Dual Task Training Dementia Mild Cognitive Impairment Older Adult Sleep Quality Behavioral Disturbance Cognition Balance Flexibility

ClinConnect Summary

This clinical trial is looking at a special kind of training called "dual-task training" to see if it can help improve thinking skills and other problems in older adults who have mild cognitive impairment or mild dementia. The study will last for 12 weeks, with participants attending training sessions three times a week for 45 minutes each time. There will be different groups in the study: one group will do the dual-task training, another will do cognitive training, and a third will do motor training, while a control group will receive regular care. The researchers want to find out if this dual-task training can improve overall thinking abilities, memory, sleep quality, balance, and flexibility.

To be eligible for the study, participants need to be at least 60 years old, able to communicate, and show some signs of thinking decline, but not have advanced dementia. They should not have recently participated in similar training programs or have serious issues with their vision or hearing. If someone qualifies and decides to join, they can expect to engage in fun and interactive training sessions designed to help improve their daily functioning and overall well-being. This study is not yet recruiting participants, but it aims to provide important insights into how training can support older adults facing these cognitive challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Older adult \>= 60 years and able to communicate
  • CDR score range from 1 to 4
  • MMSE score \>= 18
  • Complain of conscious cognitive decline.
  • Participate voluntarily and sign informed consent.
  • Exclusion Criteria:
  • Diagnosed with moderate or severe dementia.
  • Received cognitive training or motor training within six months.
  • Severe sensory function impairment (such as vision, and hearing).
  • Have limited mobility, such as those using wheelchairs or four-legged walking aids.

About Taipei Medical University

Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.

Locations

Malang, Jawa Timur, Indonesia

Patients applied

0 patients applied

Trial Officials

Nur Aini, MSc

Principal Investigator

School of Nursing, College of Nursing, Taipei Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported